Image 2_Triptolide alleviates psoriasis through inhibiting the Wnt5a/β-Catenin signaling pathway.jpeg

Image 2_Triptolide alleviates psoriasis through inhibiting the Wnt5a/β-Catenin signaling pathway.jpeg

Background<p>Psoriasis, an immune-mediated chronic inflammatory skin disease, is characterized by keratinocyte proliferation and inflammatory cell infiltration. T ripterygium wilfordii is a potential treatment option for psoriasis, and triptolide (TP) is one of its active components. TP may po...

Full description

Saved in:
Bibliographic Details
Main Author: Eryang Chen (11127828) (author)
Other Authors: Lei Wang (6656) (author), Qu Wang (15247127) (author), Yan Cai (298695) (author), Yaning Dou (21195761) (author), Hongyan Qu (8059541) (author), Junyi Zhu (6814523) (author), Haiyang Zhao (1677661) (author), Suqing Zheng (1585378) (author), Chengguang Zhao (4221556) (author), Bin Chen (63682) (author)
Published: 2025
Subjects:
Pharmacology
psoriasis
triptolide
interleukin-17A
Wnt5a/β-catenin
inflammation
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items